Disorders of aging skin

Reviews in Clinical Gerontology

Volumn 16, Issue 3, 2006, Pages 165-177

  Baldry, R J ^a   Harries, M J ^a,b   Nayeemuddin, F ^a   Rhodes, L E ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CAPSAICIN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DICLOFENAC; DITHRANOL; EMOLLIENT AGENT; GABAPENTIN; IMIQUIMOD; IVERMECTIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PERMETHRIN; PHENOTHIAZINE; PREDNISOLONE; QUINOLONE; RETINOID; STEROID; SUNSCREEN; TAR; TETRACYCLINE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VITAMIN D DERIVATIVE;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; BULLOUS PEMPHIGOID; CAUTERIZATION; CHRONIC ACTINIC DERMATITIS; COLD INJURY; CONSERVATIVE TREATMENT; CRYOTHERAPY; CUTANEOUS PARAMETERS; DECUBITUS; DERMATITIS; DERMATOMYCOSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; IMMOBILIZATION; LEG ULCER; LIGHT EXPOSURE; MELANOMA; NUTRITION; PATIENT EDUCATION; PHOTOSENSITIVITY; PITYROSPORUM OVALE; POSTHERPETIC NEURALGIA; PRURITUS; PSORIASIS; REVIEW; RISK FACTOR; SCABIES; SEBORRHEIC DERMATITIS; SEBORRHEIC KERATOSIS; SINGLE DRUG DOSE; SKIN CANCER; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION; VACCINATION; WOUND DRESSING; XEROSIS;

EID: 34547495241     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259807002134     Document Type: Review

References (68)

1. Department of Health. National Service Framework for Older People 2001.
2. Johnson M-LT. Skin conditions and related need for medical care among persons 1-74 years. United States. 1971-1974. Vital Health Statistics: Series 11, Data from the National Health Survey; no. 212, DHEW Publication no. (PHS) 79-1660. Hyattsville, ML: US Department of Health, Education and Welfare, 1978.
3. Gilchrest BA, Garmyn M, Yaar M. Aging and photoaging affect gene expression in cultured human keratinocytes. Arch Dermatol 1994; 130: 82-86.
4. Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol 2005; 11: 221-35.
5. Paus R, Peker S. Biology of hair and nails. In: Bologna JL, Jorizzo JL, Rapini RP eds. Dermatology. London: Mosby 2003: 1011.
6. Fisher GJ, Kang S, Varani J et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138:1462-70.
7. Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed 2000; 16: 239-44.
8. Kurwa HA, Marks R, Skin disorders. In: MS John Pathy eds. Principles and practice of geriatric medicine, third edition. Chichester: John Wiley & Sons, 1998: 1353-74.
9. Senior Skin Group. Looking after elderly skin - a simple guide. British Association of Dermatologists Clinical Guidelines 2006. www.bad.org.uk/healthcare/guidelines/elderly_skin_care.pdf.
10. Buxton PK. Eczema and dermatitis. In: Buxton PK. ABC of dermatology, third edition, London: BMJ Publishing Group 1998: 21-22.
11. Hunter JAA. Seventh age itch. BMJ 1985; 291: 842.
12. Mackie RM. Cutaneous Medicine. In: Mackie RM ed. Clinical Dermatology, fifth edition. Oxford: Oxford University Press 2003: 75-106.
13. Marks R. Itching and other dry skin disorders. In: Skin disease in old age, second edition. Marks R ed. London: Martin Dunitz Ltd. 1999; 81-90.
14. Psoriasis Guidelines. British Association of Dermatologists 2006. www.bad.org.uk/healthcare/guidelines.
15. Camp RDR. Psoriasis. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of dermatology, sixth edition, Vol. 3. Oxford: Blackwell Scientific Publications, 1998: 1589-694.
16. Fry L. Psoriasis. Br J Dermatol 1988; 119: 445-61.
17. Griffiths CEM, Voorhees JJ. Psoriasis, T-cells and autoimmunity. J Royal Soc Med 1996; 89: 315-9.
18. Rzany B, Weller N. Epidemiology of autoimmune skin disorders. In: Hertl M ed. Autoimmune diseases of the skin. Wien-New York: Springer Verlag, 2001: 21-38.
19. Wojnarowska F, Kirtschig G, Highet AS et al. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002; 147: 214-21.
20. Gonzales DW, Kim S, Werth VP. Bullous pemphigoid. In: Lebwohl MG, Heymann WR, Berth-Jones J et al. eds. Treatment of skin disease, comprehensive therapeutic strategies, second edition. Philadelphia, PA: Mosby Elsevier, 2005: 621-23.
21. Hawk JLM, Young AR, Ferguson J. Cutaneous photobiology. In: Burns DA, Breathnach SM, Cox N, Griffiths CEM eds. Rook's textbook of dermatology, seventh edition. Oxford: Blackwell Science Ltd. 2004; 24:1-24.
22. Sloan RW. Principles of drug therapy in geriatric patients. Am Fam Physician 1992; 45: 2709-18.
23. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163-84.
24. Alanka K, Stubb SM, Kauppinin K. Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1981-1985). Acta Derm Venereol 1989; 69: 223-26.
25. Marc A, Riedl MD, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003; 68: 1781-90.
26. Ninomiya J. [Effect of temperature, humidity and minor injury to the penetration of dermatophytes into human stratum corneum.] Nippon Ishinkin Gakkai Zasshi 2000; 41: 5-9.
27. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003; 148: 402-10.
28. Roberts DT, Bilsland DJ. Tinea capitis. In: Lebwohl MG, Heymann WR, Berth-Jones J et al. Treatment of skin disease, comprehensive therapeutic strategies, second edition. Philadelphia, PA: Mosby Elsevier, 2005: 572-74.
29. Chouela E, Abeldano A, Pellerano G et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol 2002; 3: 9-18.
30. Tucker WFG. Scabies. In: Lebwohl MG, Heymann WR, Berth-Jones J et al. Treatment of skin disease: comprehensive therapeutic strategies, second edition. Philadelphia, PA: Mosby Elsevier, 2005: 101-03.
31. Walker GJA, Johnstone PW. Interventions for treating scabies. Cochrane review, Cochrane Library, Issue 4, 2006. Oxford update software.
32. Del Giudice P. Ivermectin in scabies. Curr Opin Infect Dis 2002; 15: 123-26.
33. Gross G, Schofer H, Wassilew et al. Herpes zoster guideline of the German Dermatology Society. J Clin Virol 2003; 26: 277-89.
34. Holcomb K, Weinberg JM. A novel vaccine (Zostavax) to prevent herpes zoster and post-herpetic neuralgia. J Drugs Dermatol 2006; 5: 863-66.
35. Cullum N, Nelson EA, Flemming K et al. Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound and electromagnetic therapy. Health Technol Assess 2001; 5: 1-221.
36. Allman RM, Goode PS, Patrick MM et al. Pressure ulcer risk factors among hospitalised patients with activity limitation. JAMA 1995; 273:865-70.
37. Pressure Ulcers: The management of pressure ulcers in primary and secondary care. A clinical practical guideline. NICE Guidelines 2005.www.nice.org.uk.
38. Buxton PK. Lumps and Bumps. In: Buxton PK ed. ABC of dermatology, third edition. London: BMJ Publishing Group 1998; 81-84.
39. Marks R. Neoplastic disorders of the skin. In: Marks R ed. Skin disease in old age, second edition. London: Martin Dunitz Ltd. 1999; 183-226.
40. Parish LC, Witkowski JA. Barnacles, old age marks, or just plain seborrheic keratoses. Skin Med 2005; 4: 333-35.
41. Pearse AD, Marks R. Epidermal proliferation in actinic keratosis and in the epidermis in which they arise. Br J Dermatol 1977; 96: 45-50.
42. Spencer JM, Fulton J. Actinic keratosis. www.emedicine.com/derm/topic9. htm.
43. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; i: 795-97.
44. Akhdari N, Amal S, Ettalbi S. Bowen disease. CMAJ 2006; 175: 739.
45. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163-84.
46. Cox NH, Eedy DJ, Morton CA, on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of Bowen's disease: 2006 update. Br J Dermatol 2007; 156: 11-21.
47. Motley RJ, Gould DJ, Douglas WS et al. Treatment of basal cell carcinoma by dermatologists in the United Kingdom. Br J Dermatol 1995; 132: 437-40.
48. Miller DL, Weinstock MA. Non-melanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-78.
49. Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003; 327: 794-98.
50. Lo JS, Snow SN, Reizner GT et al. Metastatic basal cell carcinoma report of twelve cases with review of the literature. J Am Acad Dermatol 1991; 24: 715-19.
51. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999; 141:415-23.
52. Rowe DE, Carroll RJ, Day CL Jr. Mohs' surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424-31.
53. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67.
54. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28.
55. Robinson JK. Risk of developing another basal cell carcinoma. Cancer 1987; 60: 118-20.
56. Jerant AF, Johnson JT, Sheridan C et al. Early detection and treatment of skin cancer. Am Fam Physician 2000; 62: 357-82.
57. Mackie RM. Benign and malignant skin tumours. In: Mackie RM ed. Clinical Dermatology, fifth edition. Oxford: Oxford University Press 2003: 279-304.
58. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18-25.
59. Marks R. Squamous cell carcinoma. Lancet 1996; 347: 735-38.
60. Homsi J, Kashani-Sabet M, Messina JL et al. Cutaneous melanoma: prognostic factors. Cancer Control 2005; 12: 223-29.
61. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. Arch Dermatol 1996; 132: 444-50.
62. Roberts DLL, Anstey AV, Barlow RJ. UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002; 146: 7-17.
63. Tan S, Bertucci V. Erythema ab igne: an old condition new again. CMAJ 2000; 162: 77.
64. Bader RS. Erythema ab igne. www.emedicine.com/derm/topic130.htm.
65. Arrington JH, Lockman DS. Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne. Arch Dermatol 1979; 115: 1226-28.
66. Marks R. Environmental considerations. In: Skin disease in old age, second edition. London: Martin Dunitz Ltd. 1999; 15-34.
67. Dowd PM, Rustin MH, Lanigan S. Nifedipine in the treatment of chilblains. BMJ 1986; 293: 923-24.
68. Rook's Textbook of Dermatology, seventh edition. Burns DA, Breathnach SM, Cox N, Griffiths CEM eds. Oxford: Blackwell Science Ltd., 2004.